Source:http://linkedlifedata.com/resource/pubmed/id/17849408
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
18
|
pubmed:dateCreated |
2007-9-17
|
pubmed:abstractText |
To evaluate the effects of YC-1 on leukemia cell lines, PI incorporation was used to determine cell viability. YC-1 induced a dose- and time-dependent decrease in viability and apoptosis in YC-1-treated U937 cells. YC-1-induced apoptosis is a cyclic guanosine monophosphate (cGMP)-independent pathway. Proteomic analysis showed that the altered proteins include the significant regulation of HSP70, chaperonin, ATP synthase beta chains, and Chain F. Western blotting and immuno-cytochemistry stain showed that YC-1 treatment caused a time-dependent increase in cytosolic Cytochrome c, pro-caspase-9, Apaf-1, and the activation of caspase-9 and -3. Importantly, the in vivo antileukemia effects of YC-1 were evaluated in BALB/c mice inoculated with WEHI-3B orthotopic model. YC-1 enhanced survival rate and prevented the body weight loss in leukemia mice. The enlargement of spleen and lymph nodes were reduced in YC-1 treated than that in leukemia mice. H-E stain of spleen sections revealed that infiltration of immature myeloblastic cells into red pulp was reduced in YC-1-treated group. The apoptotic cells of splenocyte were significantly increased in YC-1 treated than that in leukemia mice by Tdt-mediated deoxyuridine triphosphate nick end labeling (TUNEL) assay. Taken together, we conclude that YC-1 acted against U937 cells in vitro via a mitochondrial-dependent apoptosis pathway, and in orthotopic leukemia model, YC-1 administered antileukemia activity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1615-9853
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3305-17
|
pubmed:meshHeading |
pubmed-meshheading:17849408-Animals,
pubmed-meshheading:17849408-Apoptosis,
pubmed-meshheading:17849408-Blotting, Western,
pubmed-meshheading:17849408-Electrophoresis, Agar Gel,
pubmed-meshheading:17849408-Electrophoresis, Gel, Two-Dimensional,
pubmed-meshheading:17849408-Humans,
pubmed-meshheading:17849408-Immunohistochemistry,
pubmed-meshheading:17849408-In Situ Nick-End Labeling,
pubmed-meshheading:17849408-Indazoles,
pubmed-meshheading:17849408-Leukemia, Experimental,
pubmed-meshheading:17849408-Male,
pubmed-meshheading:17849408-Mass Spectrometry,
pubmed-meshheading:17849408-Mice,
pubmed-meshheading:17849408-Mice, Inbred BALB C,
pubmed-meshheading:17849408-Neoplasm Transplantation,
pubmed-meshheading:17849408-U937 Cells
|
pubmed:year |
2007
|
pubmed:articleTitle |
Proteomic approach to studying the cytotoxicity of YC-1 on U937 leukemia cells and antileukemia activity in orthotopic model of leukemia mice.
|
pubmed:affiliation |
Departments of Microbiology, School of Biological Science and Technology, China Medical University, Taichung, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|